Table 1.

Compilation of the results of the specificity analyses with different antibodies

No.	Antibody target site	SFT	SFN	SFT/SFN
1	H3K4me1	30	3	10
2	H3K4me2	42	1.3	33
3	H3K4me2	62	3	19
4	H3K4me3	31	4	9
5	H3K4me3	32	2	16
6	H3K4me3	9	3	3
7	H3K9ac	44	1	44
8	H3K9me1	19	16	1
9	H3K9me3	18	7	2
10	H3K9me3	44	1	44
11	H3K9me3	28	3	11
12	H3K9me3	47	3	15
13	H3K9me3 S10ph	51	13	4
14	H3S10ph	48	1	48
15	H3S10ph	46	1	46
16	H3S10ph	138	1	138
17	H3K14ac	26	28	1
18	H3K27me2	18	14	1
19	H3K27me3	34	9	4
20	H3K27me3	36	10	4
21	H3K27me3	172	1	172
22	H3K27me3	74	14	5
23	H3K36me2	71	44	2
24	H3K36me3	26	23	1
25	H3K36me3	a	a	a
26	H3K36ac	504	6	85
27	H3-Pan-Kme2/me3	9b	19	1
28	H4R3me2a	77	3	31
29	H4K12ac	30	4	8
30	H4K16ac	179	1	179
31	H4K20me1	77	6	12
32	H4K20me2	228	4	61
33	H4K20me3	155	1	155
34	H4-Pan-Kac	25c	4	6
35	H4-Pan-Kac	14d	3	5
36	H2aK9ac	121	10	12

In this table, the antibody number (referring to Sup. Table 2), the antibody target site, the specificity factor for binding at the target site (SF_T) and for the best non-target site (SF_N) and the ratio of both are given. Examples of the results are shown in Supplemental Table 1.

^anot applicable since no specific binding to target.

^bcalculated for H3K9me3.

^ccalculated for K8ac or K5ac or K12ac.

^dcalculated for K12ac or K5ac or K8ac.